Prevalence of Age-Related Macular Degeneration in the United States
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the prevalence and distribution of age-related macular degeneration (AMD) in the United States by age, race/ethnicity, and gender. METHODS: Summary prevalence estimates of drusen 125 microm or larger, neovascular AMD, and geographic atrophy were prepared separately for black and white persons in 5-year age intervals starting at 40 years. The estimated rates were based on a meta-analysis of recent population-based studies in the United States, Australia, and Europe. These rates were applied to 2000 US Census data and to projected US population figures for 2020 to estimate the number of the US population with drusen and AMD. RESULTS: The overall prevalence of neovascular AMD and/or geographic atrophy in the US population 40 years and older is estimated to be 1.47% (95% confidence interval, 1.38%-1.55%), with 1.75 million citizens having AMD. The prevalence of AMD increased dramatically with age, with more than 15% of the white women older than 80 years having neovascular AMD and/or geographic atrophy. More than 7 million individuals had drusen measuring 125 microm or larger and were, therefore, at substantial risk of developing AMD. Owing to the rapidly aging population, the number of persons having AMD will increase by 50% to 2.95 million in 2020. Age-related macular degeneration was far more prevalent among white than among black persons. CONCLUSION: Age-related macular degeneration affects more than 1.75 million individuals in the United States. Owing to the rapid aging of the US population, this number will increase to almost 3 million by 2020.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845 · cited 3×
“All Participants 40-49 NA 20 20 (15-26) 0.”
Prevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Racial Differences in the Cause-Specific Prevalence of Blindness in East Baltimore
Sommer, A., Tielsch, J. M., Katz, J., Quigley, H. A., Gottsch, J. D., Javitt, J. C., Martone, J. F., Royall, R. M., Witt, K. A., & Ezrine, S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111143252004 · Cited by 764 · cited 2×
“To be included in the present research, the studies contributing data had to (1) be population based, (2) provide data on the conditions being studied; and (3) use a standard photographic grading system for determining the prevalence of AMD and drusen.”
MethodBrody, B. L., Gamst, A. C., Williams, R. A., Smith, A. R., Lau, P. W., Dolnak, D., Rapaport, M. H., Kaplan, R. M., & Brown, S. I. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00754-0 · Cited by 581
Muñoz, B. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.6.819 · Cited by 521
The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity.
Klein, R., Wang, Q., Klein, R., Moss, S. E., & Meuer, S. M. (1995) · PubMed · Cited by 458
West, S. K., Muñoz, B., Rubin, G. S., Schein, O. D., Bandeen‐Roche, K., Zeger, S. L., German, S., & Fried, L. P. (1997) · PubMed · Cited by 391
The Risk and Natural Course of Age-Related Maculopathy: Follow-up at 6½ Years in the Rotterdam Study
van Leeuwen, R. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.519 · Cited by 332
Racial differences in the prevalence of age-related macular degeneration
Friedman, D. S., Katz, J., Bressler, N. M., Rahmani, B., & Tielsch, J. M. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90267-1 · Cited by 304 · cited 3×
“Male Participants 40-49 NA NA NA NA 50-54 10 1 14 (10-17) 0.”
Age-related maculopathy in a multiracial United States population
Klein, R., Klein, B. E. K., Jensen, S. C., Mares-Perlman, J. A., Cruickshanks, K. J., & Palta, M. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90255-5 · Cited by 227
The prevalence of age-related maculopathy: the visual impairment project
VanNewkirk, M. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00175-5 · Cited by 222
The prevalence of age-related maculopathy: The visual impairment project
Mukesh, B., VanNewkirk, Wang, J., Mitchell, P. B., Taylor, H. R., & McCarty, C. A. (2000) · Investigative Ophthalmology & Visual Science · Cited by 200
Wang, J. J., Foran, S., & Mitchell, P. (2000) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2000.00315.x · Cited by 197
Activity Loss and Depression in Age-Related Macular Degeneration
Rovner, B. W., & Casten, R. J. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200205000-00010 · Cited by 195
Age-Specific Causes of Bilateral Visual Impairment
Weih, L. M. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.2.264 · Cited by 191
Features of age-related macular degeneration in a black population
Schachat, A. P. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060054032 · Cited by 171
Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics
Rodriguez, J., Sánchez, R., Muñoz, B. E., West, S. K., Broman, A. T., Snyder, R. W., Klein, R., & Quigley, H. A. (2002) · Ophthalmology · doi:10.1016/s0161-6420(01)01008-9 · Cited by 152
Klaver, C., Wolfs, R. C. W., Vingerling, H., Albert Hofman, D., & Jong, P. D. (1998) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 53
Cited by
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
Kermany, D. S., Goldbaum, M., Cai, W., Valentim, C. C. S., Liang, H., Baxter, S. L., McKeown, A., Yang, G., Wu, X., Yan, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.010 · Cited by 4,842
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Metadata
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-04-01
- Volume
- 122
- Issue
- 4
- Pages
- 564
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W1487528435
- Cited by
- 2,736
- References
- 22
- FWCI
- 94.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.